MSB 3.83% $1.26 mesoblast limited

Atherys a stem cell stock is close to approvoal with their cell...

  1. 192 Posts.
    lightbulb Created with Sketch. 137
    Atherys a stem cell stock is close to approvoal with their cell therapy for ARDS acute respritory syndrome
    Approvoal could happen very fast in Japan with their partner Healios
    Cooronavirus causes ARDS and it will be the only useful therapy.Quick approvoal for this indication will be good for whole sector


  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.26
Change
-0.050(3.83%)
Mkt cap ! $1.432B
Open High Low Value Volume
$1.27 $1.30 $1.17 $21.32M 17.21M

Buyers (Bids)

No. Vol. Price($)
4 5460 $1.25
 

Sellers (Offers)

Price($) Vol. No.
$1.26 978 1
View Market Depth
Last trade - 16.10pm 24/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.